Immunobiology and pathogenesis of hepatitis B virus infection

M Iannacone, LG Guidotti - Nature Reviews Immunology, 2022 - nature.com
Hepatitis B virus (HBV) is a non-cytopathic, hepatotropic virus with the potential to cause a
persistent infection, ultimately leading to cirrhosis and hepatocellular carcinoma. Over the …

Therapeutic potential of Toll-like receptor 9 activation

AM Krieg - Nature reviews Drug discovery, 2006 - nature.com
In the decade since the discovery that mouse B cells respond to certain unmethylated CpG
dinucleotides in bacterial DNA, a specific receptor for these'CpG motifs' has been identified …

A global scientific strategy to cure hepatitis B

PA Revill, FV Chisari, JM Block, M Dandri… - The lancet …, 2019 - thelancet.com
Chronic hepatitis B virus (HBV) infection is a global public health challenge on the same
scale as tuberculosis, HIV, and malaria. The International Coalition to Eliminate HBV (ICE …

TLR4 enhances TGF-β signaling and hepatic fibrosis

E Seki, S De Minicis, CH Österreicher, J Kluwe… - Nature medicine, 2007 - nature.com
Hepatic injury is associated with a defective intestinal barrier and increased hepatic
exposure to bacterial products. Here we report that the intestinal bacterial microflora and a …

Toll-like receptors in antiviral innate immunity

SN Lester, K Li - Journal of molecular biology, 2014 - Elsevier
Toll-like receptors (TLRs) are fundamental sensor molecules of the host innate immune
system, which detect conserved molecular signatures of a wide range of microbial …

Self-regulation and cross-regulation of pattern-recognition receptor signalling in health and disease

X Cao - Nature Reviews Immunology, 2016 - nature.com
In the initiation of innate immune responses against pathogens, pattern-recognition
receptors (PRRs) have an essential role in recognizing specific components of …

Pathogenic mechanisms in HBV-and HCV-associated hepatocellular carcinoma

A Arzumanyan, HM Reis, MA Feitelson - Nature Reviews Cancer, 2013 - nature.com
Hepatocellular carcinoma (HCC) is a highly lethal cancer, with increasing worldwide
incidence, that is mainly associated with chronic hepatitis B virus (HBV) and/or hepatitis C …

Getting to HBV cure: The promising paths forward

S Fung, HSJ Choi, A Gehring, HLA Janssen - Hepatology, 2022 - Wiley Online Library
Chronic HBV infection is a global public health burden estimated to impact nearly 300
million persons worldwide. Despite the advent of potent antiviral agents that effectively …

[PDF][PDF] Liver: an organ with predominant innate immunity

B Gao, WI Jeong, Z Tian - Hepatology, 2008 - Wiley Online Library
Blood circulating from the intestines to the liver is rich in bacterial products, environmental
toxins, and food antigens. To effectively and quickly defend against potentially toxic agents …

Republished: Innate and adaptive immune responses in chronic hepatitis B virus infections: towards restoration of immune control of viral infection

A Bertoletti, C Ferrari - Postgraduate Medical Journal, 2013 - academic.oup.com
Abstract Knowledge of the immunological events necessary to control hepatitis B virus
(HBV) infection has accelerated in recent years, but their translation towards therapeutic …